A phase 3 randomized safety and immunogenicity trial of mRNA-1010 seasonal influenza vaccine in adults

Authors

Institutions

Publication Details

Journal
Vaccine
Published
2025-02-07
DOI
https://doi.org/10.1016/j.vaccine.2025.126847
Citations
38
Primary Topic
Influenza Virus Research Studies
Type
article
Field-Weighted Citation Impact
51.46

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A phase 3 randomized safety and immunogenicity trial of mRNA-1010 seasonal influenza vaccine in adults

Greg Livermore, Bryony Hicks, Raffael Nachbagauer, Kathryn Jean Lucas et al.
38 citations
Vaccine
Influenza Virus Research Studies
51.46
article

A phase 3 randomized safety and immunogenicity trial of mRNA-1010 seasonal influenza vaccine in adults

Greg Livermore, Bryony Hicks, Raffael Nachbagauer, Kathryn Jean Lucas, Andrei Avanesov, Mieke Soens, Evelyn Du, Kristi Schaefers, Angela Choi, Jacqueline M. Miller, Carole Henry, José F. Cardona, Alicia Pucci, Rituparna Das, Lawrence Sher, Jintanat Ananworanich, Ren Chen
article en
38 citations

Abstract

No abstract available for this paper.
VaccineVol. 50
Lucas Research (US), Moderna Therapeutics (United States) (US), Peninsula Research (US), Micropharma (Canada) (CA), University of Science and Technology Chittagong (BD)
Moderna
Good health and well-being
Openalex Percentile: Top 0%
Influenza Virus Research Studies
51.46
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.